Artiva Biotherapeutics, Inc. (ARTV) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$47.43M2024: -$55.03M2025: -$76.75M-$76.75M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$76.75M-39.5%
2024-$55.03M-16.0%
2023-$47.43M